Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Total 13F shares
-
9,203,739
-
Share change
-
+1,386,982
-
Total reported value
-
$142,654,000
-
Price per share
-
$15.50
-
Number of holders
-
28
-
Value change
-
+$21,828,053
-
Number of buys
-
15
-
Number of sells
-
10
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q4 2014
As of 31 Dec 2014 EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) had 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,203,739 shares of stock of the company.
Largest 10 holders included ProQuest Associates IV LLC, GENERAL ELECTRIC CO, Park West Asset Management LLC, JENNISON ASSOCIATES LLC, Cormorant Asset Management, LLC, DEERFIELD MANAGEMENT CO, THOMSON HORSTMANN & BRYANT INC, Camber Capital Management LLC, WALL STREET ASSOCIATES, and Allianz Asset Management AG.
This table shows 28 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.